Translation News and Research

RSS

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.

10 May 2011

Researchers analyze gene expression profiles to understand molecular mechanisms behind various diseases

Over the past decades, researchers seeking to understand molecular mechanisms underlying various diseases, notably cancer, have taken advantage of DNA microarrays to interrogate tissues specimen of patients for the expression status of thousands of genes at once.

9 May 2011

CDRD reaches agreement with University of Calgary, UTI to develop promising drug candidates

The Centre for Drug Research and Development announced today the signing of affiliation agreements with both the University of Calgary and University Technologies International.

6 May 2011

Scripps Research receives CIRM grant for new research in stem cell biology and disease origins

Stem cells have huge potential in medicine because they have the ability to change or differentiate into many different cell types potentially providing a source of cells to replace those that have been permanently lost by a patient.

6 May 2011

Mylan reports EPS of $0.44 for three months ended March 31, 2011

Mylan Inc. today announced its financial results for the three months ended March 31, 2011.

3 May 2011

NCI survey: Most people do not know much about clinical trials

Most people don't know much about clinical trials, according to surveys across all races and groups. Yet many members of the Hispanic community fear and distrust doctors, hospitals, and medical research. Part of this distrust may have come from the legacy of enforced sterilizations that Latinas experienced before World War II in Puerto Rico.

2 May 2011

Stanford University creates first stem cell science PhD program in U.S.

Stanford University’s Faculty Senate has approved the creation of what officials believe is the first stem cell science PhD program in the nation and, perhaps, the world. The new doctoral program in stem cell biology and regenerative medicine is also the first interdisciplinary doctoral program created by the School of Medicine in recent years.

1 May 2011

UofL nursing professor receives Outstanding Faculty Practice award

Providing healthcare to the backside workers at Churchill Downs has been the passion of Whitney Nash, PhD, MSN, APRN-BC, assistant professor, University of Louisville School of Nursing, since 2005.

30 Apr 2011

Bruker first quarter revenue increases 29% to $357.0 million

Bruker Corporation today reported financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Invacare first quarter earnings per share increases 156% to $0.23

Invacare Corporation today announced its financial results for the quarter ended March 31, 2011.

28 Apr 2011

Thermo Fisher revenues increase 4% to $2.72 billion for first quarter 2011

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.

From Thermo Fisher Scientific Inc. 27 Apr 2011

Waters first quarter sales rise 16% to $428 million

Waters Corporation reported first quarter 2011 sales of $428 million, an increase of 16%, from sales of $368 million in the first quarter of 2010. In the quarter, foreign currency translation added 2% to sales growth.

26 Apr 2011

OCM announces acquisition of Diagnostics Plus

One Call Medical, the nation's leading provider of specialty services to insurance payers, today announced its acquisition of Diagnostics Plus, a provider network for advanced radiology and electrodiagnostic services, including MRIs, CT scans, and electromyography.

25 Apr 2011

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.

25 Apr 2011

New trial in UK to test whether statins could be used to treat pre-eclampsia

Pregnant women could benefit from a pioneering trial that will test whether heart disease drugs can be used to treat pre-eclampsia.

21 Apr 2011

U.S. DOD awards $4.5M to NYU Langone Medical Center for novel breast cancer research

NYU Langone Medical Center announced today the U.S. Department of Defense Breast Cancer Research Program of the Office of the Congressionally Directed Medical Research Programs has awarded Silvia Formenti, MD, the Sandra and Edward Meyer Professor and Chair of the Department of Radiation Oncology a $4.5 million Multi-Team Award to conduct novel breast cancer research.

21 Apr 2011

St. Jude Medical first quarter net sales increases 9% to $1.376 billion

St. Jude Medical, Inc. today reported sales and net earnings for the first quarter ended April 2, 2011.

20 Apr 2011

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.

From Precision NanoSystems Inc. 20 Apr 2011

Springer to publish new journal of Society of Behavioral Medicine

Starting in 2011, Springer will publish Translational Behavioral Medicine: Practice, Policy, Research (TBM), a journal of the Society of Behavioral Medicine. The journal will debut with a special section, "Information Technology and Evidence Implementation."

20 Apr 2011

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.

20 Apr 2011

Translation News and Research

MGH, Duke University and Angion Biomedica partner to develop novel therapeutics for ischemic stroke

Researchers analyze gene expression profiles to understand molecular mechanisms behind various diseases

CDRD reaches agreement with University of Calgary, UTI to develop promising drug candidates

Scripps Research receives CIRM grant for new research in stem cell biology and disease origins

Mylan reports EPS of $0.44 for three months ended March 31, 2011

NCI survey: Most people do not know much about clinical trials

Stanford University creates first stem cell science PhD program in U.S.

UofL nursing professor receives Outstanding Faculty Practice award

Bruker first quarter revenue increases 29% to $357.0 million

Invacare first quarter earnings per share increases 156% to $0.23

Thermo Fisher revenues increase 4% to $2.72 billion for first quarter 2011

Waters first quarter sales rise 16% to $428 million

OCM announces acquisition of Diagnostics Plus

Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress

New trial in UK to test whether statins could be used to treat pre-eclampsia

U.S. DOD awards $4.5M to NYU Langone Medical Center for novel breast cancer research

St. Jude Medical first quarter net sales increases 9% to $1.376 billion

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Springer to publish new journal of Society of Behavioral Medicine

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News